Basophil responsiveness in chronic urticaria

被引:36
作者
Saini, Sarbjit S. [1 ]
机构
[1] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA
关键词
CHRONIC IDIOPATHIC URTICARIA; FC-EPSILON-RI; AFFINITY IGE RECEPTOR; MAST-CELL DEGRANULATION; QUALITY-OF-LIFE; HISTAMINE-RELEASE; INOSITOL 5'-PHOSPHATASE; INFILTRATING CELLS; DISEASE-ACTIVITY; AUTOANTIBODIES;
D O I
10.1007/s11882-009-0040-3
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Chronic urticaria is a common skin disease without an etiology in the majority of cases. The similarity of symptoms and pathology to allergen-induced skin reactions supports the idea that skin mast cell and blood basophil IgE receptor activation is involved; however, no exogenous allergen trigger has been identified. Recent evidence supports a role for blood basophils in disease expression. Specifically, blood basopenia is noted in active disease with the recruitment of blood basophils to skin lesional sites. In addition, blood basophils display altered IgE receptor-mediated degranulation that reverts in disease remission. In active chronic idiopathic urticaria (CIU) subjects, changes in IgE receptor-signaling molecule expression levels accompany the altered degranulation function in blood basophils. The arrival of therapies targeting IgE has further shown that altered blood basophil degranulation behavior has potential use as a disease biomarker in CIU.
引用
收藏
页码:286 / 290
页数:5
相关论文
共 46 条
[31]   Relationship between spleen tyrosine kinase and phosphatidylinositol 5′ phosphatase expression and secretion from human basophils in the general population [J].
MacGlashan, Donald W., Jr. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (03) :626-633
[32]   Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1 [J].
Morgan, Matt ;
Khan, David A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (05) :403-411
[33]  
Mukai Kaori, 2009, Allergology International, V58, P11, DOI 10.2332/allergolint.08-RAI-0059
[34]   Basophils are essential initiators of a novel type of chronic allergic inflammation [J].
Obata, Kazushige ;
Mukai, Kaori ;
Tsujimura, Yusuke ;
Ishiwata, Kenji ;
Kawano, Yohei ;
Minegishi, Yoshiyuki ;
Watanabe, Naohiro ;
Karasuyama, Hajime .
BLOOD, 2007, 110 (03) :913-920
[35]  
ODonnell BF, 1997, BRIT J DERMATOL, V136, P197
[36]   Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria:: Comparison of patients with and without anti-FcεRI or anti-IgE autoantibodies [J].
Sabroe, RA ;
Poon, E ;
Orchard, GE ;
Lane, D ;
Francis, DM ;
Barr, RM ;
Black, MM ;
Black, AK ;
Greaves, MW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (03) :484-493
[37]   Anti-FcεRI autoantibodies land basophil histamine releasability in chronic idiopathic urticaria [J].
Sabroe, RA ;
Francis, DM ;
Barr, RM ;
Black, AK ;
Greaves, MW .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (04) :651-658
[38]   INHIBITION OF BASOPHIL HISTAMINE-RELEASE BY ANTI-INFLAMMATORY STEROIDS [J].
SCHLEIMER, RP ;
LICHTENSTEIN, LM ;
GILLESPIE, E .
NATURE, 1981, 292 (5822) :454-455
[39]   Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they? [J].
Sheikh, J .
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 5 (05) :403-407
[40]   MAST-CELL NUMBER AND PHENOTYPE IN CHRONIC IDIOPATHIC URTICARIA [J].
SMITH, CH ;
KEPLEY, C ;
SCHWARTZ, LB ;
LEE, TH .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 96 (03) :360-364